Patricia Salazar Villegas
Quick facts
Marketed products
- TAP block with Bupivacaine at 0.25% · Anesthesia/Pain Management
Bupivacaine blocks sodium channels in nerve fibers to provide local anesthesia when infiltrated into the transversus abdominis plane (TAP).
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Patricia Salazar Villegas
What are Patricia Salazar Villegas's marketed drugs?
Top marketed products include TAP block with Bupivacaine at 0.25%.
Related
- TAP block with Bupivacaine at 0.25% · Anesthesia/Pain Management
- Sector hub: All tracked pharma companies